{"nct_id":"NCT02448810","title":"Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer","status":"TERMINATED","status_verified_date":"2021-05","start_date":"2015-06-15","start_date_type":"ACTUAL","primary_completion_date":"2017-02-15","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}